X4 Pharmaceuticals
Biotechnology company developing treatments for rare diseases and cancers by targeting the CXCR4 pathway, a critical regulator of immune cell trafficking. Publicly traded on NASDAQ (XFOR).
Website
https://www.x4pharma.comLocation
Boston, Massachusetts, USA
Founded
2015
Investors
1
Categories
biotech, oncology, rare-disease, immunology, public-company
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |